CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Finland
August 2018
140
About the Report
About the Report
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Finland
Summary
GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Finland". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Finland. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Finland. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.
Finland is one of the rapidly emerging markets in the EU, with a strong focus on pharmaceutical R&D. It spends approximately 9.4% of its GDP on healthcare. The pharmaceutical market value decreased from USD 2.50 billion in 2010 to USD 2.47 billion in 2015 at negative CAGR of 0.26%, owing to an increase in generic volume from 34% in 2010 to 42% in 2015. It is expected to reach USD 2.65 billion in 2022. However, the market value in terms of Euros was EUR1.89 billion in 2010 and increased at a CAGR of 3% from 2015. It is expected to reach EUR2.80 billion in 2022. The Finnish medical device market was valued at USD 0.99 billion in 2010, which increased to USD 1.27 billion in 2017. The main segments were cardiovascular devices, diabetes care devices, in vitro diagnostics, orthopedic devices and ophthalmic devices. The increasing elderly population, favorable foreign investment environment and tremendous innovation are expected to drive the growth of the pharmaceutical market. However, generic substitution, increased healthcare expenditure and presence of counterfeit medicines act as a major barrier for the pharmaceutical market.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Finland, and includes-
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Pfizer, GSK, Sanofi and Orion) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche, DePuy, Zimmer Biomet and Revenio)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Finland
- Porter's five forces analysis for pharmaceutical and medical devices market of Finland
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Finnish healthcare market.
Reasons to buy
This report will enhance your decision-making capability by allowing you to-
- Develop business strategies by understanding the trends shaping and driving the Finnish healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Finnish healthcare market.
Products
Products
Finland, Pharmaceutical Market, Medical Devices, Drivers and Barriers, Major Players, Regulatory landscape, Reimbursement landscape, Deals, Porter Five Forces,Opportunities and Challenges
Table of Contents
Table of Contents
Table of Contents
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter's Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix
List of Figure
List of Figures
Figure 1: Pharmaceutical Market, Finland, Revenue, 2010-2017 8
Figure 2: Medical Device Market, Finland, Revenue, 2010-2017 8
Figure 3: Total Generics Sales (by value), Finland, (%), 2015 8
Figure 4: Number of Deals (2017-2018) 12
Figure 5: 2017-2018 Deal Overview By Region 12
Figure 6: Country Profile, Finland, 2018 14
Figure 7: Pharmaceutical Market, Finland, Revenue, 2010-2017 16
Figure 8: Pharmaceutical Market, Finland, Revenue Forecast, 2018-2022 16
Figure 9: Pharmaceutical Market, Finland, Pharmaceutical Exports 17
Figure 10: Pharmaceutical Market, Finland, Top Export Partners 17
Figure 11: Pharmaceutical Market, Finland, Pharmaceutical Imports 18
Figure 12: Pharmaceutical Market, Finland, Top Import Partners 18
Figure 13: Pharmaceutical Market, Finland, Supply Channels 19
Figure 14: Pharmaceutical Market, Finland, Supply Channels, Pharmacies 19
Figure 15: Pharmaceutical Market, Finland, Sales of Patented Drug Products by Major Therapeutic Class, 2016 21
Figure 16: Pharmaceutical Market, Finland, Major Players 23
Figure 17: Medical Device Market, Finland, Revenue, 2010-2017 40
Figure 18: Medical Device Market, Finland, Revenue Forecast, 2018-2022 40
Figure 19: Medical Device Market, Finland, Revenue by Segment, 2017 41
Figure 20: Cardiovascular Market, Finland, Revenue 42
Figure 21: Cardiovascular Market, Finland, Market Share of Major Players 42
Figure 22: Diabetes Care Devices Market, Finland, Revenue 43
Figure 23: Diabetes Care Devices Market, Finland, Market Share of Major Players 43
Figure 24: In Vitro Diagnostics Devices Market, Finland, Revenue 44
Figure 25: In Vitro Diagnostics Devices Market, Finland, Market Share of Major Players 44
Figure 26: Orthopedic Devices, Finland, Revenue 45
Figure 27: Orthopedic Devices, Finland, Market Share of Major Players 45
Figure 28: Ophthalmic Devices Market, Finland, Revenue 46
Figure 29: Ophthalmic Devices Market, Finland, Market Share of Major Players 46
Figure 30: Diagnostic Market, Finland, Revenue (USD bn), 2010-2017 47
Figure 31: Diagnostic Market, Finland, Revenue Forecast (USD bn), 2018-2022 47
Figure 32: Medical Device Market, Finland, Revenue of Major Players 49
Figure 33: Deal Value and Deal Count, Pharmaceutical Market, Finland, 2017-2018 69
Figure 34: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Finland, 2017 69
Figure 35: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Finland, 2017-2018 69
Figure 36: Top Five Therapy Area by Deal Value, Pharmaceutical Market, Finland, 2017-2018 70
Figure 37: Top Five Therapy Area by Deal number, Pharmaceutical Market, Finland, 2017-2018 70
Figure 38: Venture Financing Deals by Therapy Area, Pharmaceutical Market, Finland, 2017-2018 70
Figure 39: Medical Device Market Deals, Finland, 2017-2018 (by deal value, USD m) 71
Figure 40: Medical Device Market Deals, Finland, 2017-2018 (by deal count) 71
Figure 41: Medical Device Market Deals Share (by deal count), Finland, 2017-2018 71
Figure 42: Medical Device Market Deals Share (by deal value), Finland, 2017-2018 71
Figure 43: Top Therapy Area by Deal Value, Medical Device, Finland, 2017-2018 72
Figure 44: Top Therapy Area by Deal Number, Medical Device, Finland, 2017-2018 72
Figure 45: M&A Deals by Therapy Area, Medical Device, Finland, 2017-2018 (by value and by number) 72
Figure 46: Venture Financing Deals by Therapy Area, Medical Device, Finland, 2017-2018 (by value and by number) 72
Figure 47: Private Equity Deals by Therapy Area, Medical Device Finland, 2017-2018 (by value and by number) 72
Figure 48: Healthcare System, Finland 77
Figure 49: Reimbursement Process, Finland 79
Figure 50: Medical Reimbursement System, Finland 80
Figure 51: Out-of-Pocket Expenditure (% of total expenditure on health) 84
Figure 52: Annual Rate of Change (%), Health Price Index, Finland 84
Figure 53: FIMEA, Organizational Structure, Finland 87
Figure 54: Life Cycle of Outpatient Medicine, Finland 89
Figure 55: Centralized Procedure, 2017, Finland 91
Figure 56: Decentralized Procedure, 2017, Finland 92
Figure 57: Mutual Recognition Procedure, 2017, Finland 93
Figure 58: Life Cycle of Medical Devices, Finland 94
Figure 59: Conformity Assessment of Class I Medical Devices, EU, 2017 96
Figure 60: Conformity Assessment of Class IIa Medical Devices, EU, 2017 97
Figure 61: Conformity Assessment of Class IIb Medical Devices, EU, 2017 98
Figure 62: Conformity Assessment of Class III Medical Devices, EU, 2017 99
Figure 63: European Patent Approval Process, EU, 2017 103
Figure 64: Unitary Patent Approval Process, EU, 2017 104
Figure 65: Trademark Approval Process, Finland, 2018 105
Figure 66: Number of Hospitals, Finland, 2010-2017 113
Figure 67: Diagnostic Equipment, Finland, 2010-2017 113
Figure 68: Hospital Beds (per 1,000 population), Finland 114
Figure 69: Acute Care Hospital Beds (per 1,000 population), Finland 114
Figure 70: Psychiatric Hospital Beds (per 1,000 population), Finland 114
Figure 71: Life Expectancy, 2010-2017, Finland 115
Figure 72: Immunization Rate (%), 2010-2017, Finland 115
Figure 73: PM2.5 (?g per m3), Finland, 2010-2016 116
Figure 74: CO Emissions (million tons), Finland, 2010-2016 116
Figure 75: Physicians (per 1,000 population), Finland, 2010-2016 117
Figure 76: Nurses (per 1,000 population), Finland, 2010-2016 117
Figure 77: Dentists (per 1,000 population), Finland, 2010-2016 117
Figure 78: Pharmacists (per 1,000 population), Finland, 2010-2016 117
Figure79: Major Causes of Mortality (per 100,000 population), Finland, 2015 118
Figure 80: Major Causes of Male Mortality, Finland, 2015 118
Figure 81: Major Causes of Female Mortality, Finland, 2015 118
Figure 82: Disability-Adjusted Life Years by Major Disease ('000), Finland, 2016 118
Figure 83: Healthcare Expenditure as Percentage of GDP (%), Finland, 2010-2017 119
Figure 84: Public-Private Share (%), Finland, 2010-2016 119
Figure 85: Major Components of Healthcare Spending (%), Finland, 2016 120
Figure 86: Opportunities and Challenges, Finland 124
List of Table
List of Tables
Table 1: Pharmaceutical Market, Finland, Sales of Patented Drug Products by Major Therapeutic Class (USD m), 2016 21
Table 2: Pharmaceutical Market, Finland, Sales of Major Drug Categories by Major Therapeutic Class (USD m), 2016 21
Table 3: Medical Device Market, Finland, Revenue by Segment 41
Table 4: Cardiovascular Devices Market, Finland, Revenue and Market Share of Major Players 42
Table 5: Diabetes Care Devices Market, Finland, Revenue and Market Share of Major Players 43
Table 6: In Vitro Diagnostics Devices Market, Finland, Revenue and Market Share of Major Players 44
Table 7: Orthopedic Devices Market, Finland, Revenue and Market Share of Major Players 45
Table 8: Ophthalmic Devices Market, Finland, Revenue and Market Share of Major Players 46
Table 9: Reimbursement for Medical Expenses, Finland 79
Table 10: Exceptional Copayment Rate for Specific Medicines, Finland 80
Table 11: Market Authorization Fees, 2017, Finland 90
Table 12: Patent Fees, 2017, Finland 102
Table 13: Pharmacy Tax for a Pharmacy Owning a Subsidiary Pharmacy 109
Table 14: Package Label Information, Finland, 2017 110
Table 15: Trade Associations, Finland 121
Table 16: Trade Fairs, Finland 122
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.